chr5-32765351-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_001204375.2(NPR3):c.1060-9357C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0389 in 152,246 control chromosomes in the GnomAD database, including 134 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.039 ( 134 hom., cov: 32)
Consequence
NPR3
NM_001204375.2 intron
NM_001204375.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.355
Publications
5 publications found
Genes affected
NPR3 (HGNC:7945): (natriuretic peptide receptor 3) This gene encodes one of three natriuretic peptide receptors. Natriutetic peptides are small peptides which regulate blood volume and pressure, pulmonary hypertension, and cardiac function as well as some metabolic and growth processes. The product of this gene encodes a natriuretic peptide receptor responsible for clearing circulating and extracellular natriuretic peptides through endocytosis of the receptor. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
NPR3 Gene-Disease associations (from GenCC):
- Boudin-Mortier syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0389 (5918/152246) while in subpopulation NFE AF = 0.0464 (3156/68018). AF 95% confidence interval is 0.045. There are 134 homozygotes in GnomAd4. There are 2774 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 134 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0388 AC: 5910AN: 152128Hom.: 134 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5910
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0389 AC: 5918AN: 152246Hom.: 134 Cov.: 32 AF XY: 0.0373 AC XY: 2774AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
5918
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
2774
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
1695
AN:
41536
American (AMR)
AF:
AC:
536
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
91
AN:
3468
East Asian (EAS)
AF:
AC:
7
AN:
5182
South Asian (SAS)
AF:
AC:
50
AN:
4826
European-Finnish (FIN)
AF:
AC:
219
AN:
10604
Middle Eastern (MID)
AF:
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3156
AN:
68018
Other (OTH)
AF:
AC:
88
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
300
600
901
1201
1501
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
33
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.